Levothyroxine Sodium Tablet
Product Images NDC 51655-529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 529 52 Rev A 01 21)

Label (51655 529 52   Rev A 01 21)
This is a description for Levothyroxine Sodium Tablets, USP, with a strength of 88mcg (0.088mg). The package contains 30 tablets and it is for prescription use only. The recommended dosage can be found in the package insert. The tablets should be stored at a temperature between 20°C - 25°C (68°F - 77°F) and in a tightly closed, original container, protected from light and moisture. The product has been repackaged by Northwind Pharmaceuticals in Indianapolis, IN and it was originally manufactured by Mylan Pharmaceuticals Inc. The Lot number, GTIN, Serial Number, and expiration date are not provided.*
FDA Label Image

Levothyroxine Sodium Structural Formula (Image 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.